Hims(HIMS)
Search documents
Hims & Hers Stock Chart Points to Strong Bullish Continuation
MarketBeat· 2025-05-20 14:16
Hims and Hers, Inc. NYSE: HIMS shows strongly bullish signs that begin and end with the stock price action. It reflects volatility, but the bias is upward with rising support and the most recent swing, a bullish rebound, looks very strong within the pattern. Hims & Hers Health TodayHIMSHims & Hers Health$61.95 -0.39 (-0.63%) 52-Week Range$13.47▼$72.98P/E Ratio141.24Price Target$37.67Add to WatchlistIt consists of Three White Soldiers or Three Green Soldiers, technically, a bullish pattern formed by three c ...
Here's Why You Should Add Hims & Hers Stock to Your Portfolio Now
ZACKS· 2025-05-19 12:06
Core Insights - Hims & Hers Health is positioned for growth in a $360 million healthcare market, focusing on mental health, weight loss, and dermatology, with over 2 million subscribers driving recurring revenues [1][2] - The company aims to generate $100 million from new categories by 2025, investing in GLP-1 weight-loss solutions and advanced technologies [1][9] Personalized Product Offering - Hims & Hers emphasizes personalized solutions, with over 70% of new subscribers opting for tailored products in Q1 2025, up from nearly 17% in 2022 [4][5] - Innovations include various dosage forms, enhancing customer preferences and clinical requirements [4] Rising Recurring Revenue - The subscriber base reached 2.4 million in Q1 2025, a 38% year-over-year increase, with monthly average revenue per subscriber rising 50% to $84 [6] - Online revenues surged 115.3% year-over-year to $576.4 million in Q1 2025, driven by increased platform traffic [12][13] Newer Categories to Achieve Scale - Hims & Hers plans to launch liraglutide, a generic GLP-1 medication, in 2025, aiming for significant revenue growth in weight loss [9] - The company is enhancing compounding pharmacy capabilities to support adjacent categories like mental health and dermatology [10] Strong Q1 Results - The company reported better-than-expected results in Q1 2025, with gross profit increasing 87.9% year-over-year to $430.7 million [11][13] - Operating profit surged 484.6% from the previous year, indicating strong operational performance [13] Competitive Landscape - Hims & Hers faces competition from companies like Teladoc and Amazon Pharmacy but differentiates itself through personalized, vertically integrated solutions [16][17] - The company focuses on underserved areas like women's health to mitigate competitive risks [17] Estimate Trend - The Zacks Consensus Estimate for 2025 earnings per share has improved by 12.5% to 74 cents, reflecting positive market sentiment [18] - Full-year revenue estimates are pegged at $2.34 billion, indicating a 58.4% improvement from the previous year [19]
Hims & Hers Stock Declines 3.1% in 3 Months: Is it a Buy Now?
ZACKS· 2025-05-16 15:26
Hims & Hers Health, Inc.’s (HIMS) investors have been experiencing some short-term losses from the stock of late, since mid-February, as the San Francisco, CA-based health and wellness platform’s stock has faced certain challenges. Although HIMS has lost 3.1% in the last three months, the stock has outperformed the industry’s 12.2% decline. It has also outperformed the broader Medical sector and S&P 500’s 10.9% and 3.8% declines, respectively.A major development of HIMS in recent months has included the lon ...
Hims & Hers: Growth, Strategic Partnerships, And Operational Leverage (Upgrade)
Seeking Alpha· 2025-05-16 09:00
Group 1 - The article discusses the analytical approach of Stephen, who combines clinical insight with valuation methods to analyze healthcare and tech stocks [1] - Stephen specializes in scenario-based DCF modeling, sensitivity analysis, and Monte Carlo simulations to identify asymmetric risk-reward opportunities [1] - The focus is on translating complex scientific and market dynamics into actionable investment theses [1] Group 2 - The article emphasizes the importance of independent verification of information and conducting thorough research before making investment decisions [3] - It highlights that past performance is not indicative of future results and that no specific investment recommendations are provided [4]
Hims & Hers Health (HIMS) FY Conference Transcript
2025-05-15 15:40
Hims & Hers Health (HIMS) FY Conference Summary Company Overview - **Company**: Hims & Hers Health (HIMS) - **Date of Conference**: May 15, 2025 - **Key Speakers**: Niels Law (Managing Director at JPMorgan), Yemi Okupe (CFO of Hims and Hers) Core Industry Insights - **Industry**: Telehealth and Personalized Healthcare - **Market Focus**: Addressing sensitive health conditions through technology and personalized care Key Points and Arguments Company Evolution and Strategy - Hims and Hers was founded to revolutionize healthcare by applying technology and marketing to enhance consumer experience in healthcare, which has traditionally been consumer-unfriendly [3][4] - The company has evolved to focus on personalization, allowing for tailored treatments that address individual health needs and preferences [4][5] Financial Performance and Growth Targets - For FY 2030, Hims and Hers targets $6.5 billion in revenue and $1.3 billion in adjusted EBITDA, reflecting confidence in business momentum and consumer feedback [6][7] - The subscriber base has shifted significantly towards personalized products, with over 60% of subscribers opting for personalized solutions, up from less than 15% three years ago [6][7] Personalization and Consumer Experience - Personalization is a key differentiator, with the company focusing on unique form factors and dosages to enhance treatment adherence [10][11] - The company has acquired a lab diagnostic facility to deepen personalization and provide comprehensive health insights to consumers [7][8] International Expansion and Market Opportunities - Hims and Hers plans to leverage its success in the U.S. to expand into international markets, either organically or through strategic acquisitions [8][9] - The company is excited about the potential of AI and data to transform consumer experiences and improve treatment outcomes [9][10] Specialty Areas and Product Development - The company is expanding its offerings in various specialties, including weight loss, sexual health, and dermatology, with significant growth rates reported [28][29] - The partnership with Novo Nordisk aims to enhance weight loss offerings and provide more choices to consumers [22][23] Lab Testing and Diagnostics - Hims and Hers is scaling its lab diagnostic capabilities to reduce barriers for consumers seeking hormonal therapies and health optimization [34][35] - The company aims to democratize access to health optimization services, making them more affordable and accessible [36][37] Mergers and Acquisitions Strategy - The company evaluates M&A opportunities biannually, focusing on strategic acquisitions that enhance capabilities rather than merely consolidating revenue [38][39] - Recent acquisitions have included capabilities in compounding and lab diagnostics to accelerate corporate strategy [40] Brand Development and Market Positioning - Hims and Hers aims to become synonymous with high-quality personalized care, investing in brand awareness and consumer education [61][62] - The company envisions a future where it curates the best healthcare services, similar to how Netflix curates content [63][64] Future Outlook - Over the next five years, Hims and Hers plans to deepen personalization, expand internationally, and leverage technology to enhance consumer engagement [63][67] - New specialties, including low testosterone and menopausal support, are expected to launch, alongside innovations in health optimization [67] Additional Important Insights - The company emphasizes data privacy while utilizing aggregated data for personalization, ensuring consumer trust [44][48] - Hims and Hers is focused on providing a seamless experience for both consumers and healthcare providers, enhancing clinical excellence through technology [52][54] This summary encapsulates the key insights and strategic directions discussed during the conference, highlighting Hims and Hers' commitment to transforming healthcare through technology and personalized care.
Hims & Hers Health, Inc. (HIMS) is a Great Momentum Stock: Should You Buy?
ZACKS· 2025-05-14 17:01
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.While many investors like to look for moment ...
Top Health & Fitness Stocks to Buy for the Wellness Boom
ZACKS· 2025-05-14 14:01
Industry Overview - The health and fitness industry is experiencing significant growth driven by increased public interest in wellness and healthier lifestyles, leading to higher demand for gyms, supplements, and holistic services [2] - Technological advancements, particularly wearable devices and digital platforms, are facilitating progress tracking and motivation for individuals [2] - Concerns regarding obesity, chronic illnesses, and mental health are further encouraging the adoption of fitness-focused lifestyles [2] Market Projections - The global health and wellness market is projected to reach approximately $1.1 trillion by 2034, with a compound annual growth rate (CAGR) of 7.33% from 2025 [4] - The focus on preventive care, corporate wellness programs, and government initiatives is sustaining market momentum [4] - The rise of boutique fitness and premium wellness clubs is creating opportunities for specialized offerings, as consumers increasingly view health as an integrated concept encompassing fitness, nutrition, and mental well-being [4] Key Players - **Sprouts Farmers Market (SFM)**: Specializes in fresh, natural, and organic products, with over 23% of its revenue in 2024 coming from its private-label brand. The company operates 440 stores across 24 states and is expanding with a focus on smaller-format locations [7][8] - **Hims & Hers Health (HIMS)**: A digital health platform offering personalized solutions for various health conditions, including weight management. The company has launched new products and capabilities to support long-term growth in the wellness segment [10][12] - **DexCom (DXCM)**: Focuses on continuous glucose monitoring (CGM) systems for diabetes management and metabolic health. The company is expanding its reach into wellness and preventive care through strategic product development and partnerships [14][15] Investment Opportunities - The growing emphasis on wellness presents long-term investment opportunities in fitness, nutrition, and digital health services, with companies like Sprouts, Hims & Hers, and DexCom positioned as strong candidates for investment [5]
北美消费市场,正在发生哪些变化?
Hu Xiu· 2025-05-14 09:22
Core Viewpoint - The North American consumer market is undergoing significant changes, with traditional retail brands facing challenges while new consumer brands are rapidly emerging and capturing market share [3][4][7]. Group 1: Market Trends - Bubble Mart's LABUBU 3.0 has generated significant consumer interest, indicating a shift towards collectible fashion toys, contributing to a billion-dollar market [1][3]. - In 2024, Bubble Mart's revenue is projected to reach 13.04 billion yuan, with a market capitalization exceeding 230 billion yuan, and a staggering 895%-900% year-on-year growth in the Americas market [3]. - Traditional retail giants like Macy's and Forever 21 are closing stores, highlighting the decline of conventional retail models [3][4]. Group 2: Emerging Brands - Hims&Hers has seen a 69% year-on-year revenue increase, reaching $1.477 billion in 2024, with a gross margin exceeding 83% and a subscription user base of 2.2 million [9][20]. - Native, a personal care brand, has successfully captured the natural deodorant market, achieving over $100 million in revenue by focusing on natural ingredients and consumer preferences [29][34]. - W-Labs, founded by influencers, is redefining brand strategies by decoupling from individual influencer identities and focusing on broader brand narratives [43][44]. Group 3: Consumer Behavior - The Z generation, accounting for 26% of the North American population, is becoming the primary consumer group, prioritizing brand values and emotional connections over price [13][14]. - Hims&Hers has effectively addressed consumer pain points related to sensitive health issues, utilizing social insights and modern branding to resonate with younger audiences [15][19]. - Native's approach to market entry involved rapid testing and iteration based on consumer feedback, allowing for quick adaptation to market demands [31][34]. Group 4: Entrepreneurial Resilience - Chinese entrepreneurs in North America, like Velotric, are demonstrating agility and resilience by focusing on product quality and customer engagement rather than competing solely on price [5][54][60]. - GrubMarket pivoted from B2C to B2B during logistical challenges, showcasing adaptability in response to market conditions [58]. - Victoria Tsai's brand evolution reflects a shift towards modern interpretations of cultural heritage, resulting in a 23% revenue increase in 2024 [59][60].
Hims & Hers Health Stock: A Rare High-Growth Value Play In Plain Sight
Seeking Alpha· 2025-05-12 15:15
Core Viewpoint - The article discusses the investment position in HIMS, highlighting it as a significant holding in the author's portfolio, second only to Palantir, indicating strong confidence in the company's future performance [3]. Company Summary - HIMS is identified as the second largest single stock position for the author, with ownership of 1,400 shares at an average price of approximately $36 [3]. - The author expresses a willingness to increase their position in HIMS if the stock experiences a correction, suggesting a bullish outlook on the company's potential [3]. Investment Context - The author has a beneficial long position in HIMS, indicating a positive sentiment towards the stock and its future growth prospects [2].
Buy 5 Health and Fitness Stocks to Enhance Your Portfolio Returns
ZACKS· 2025-05-12 14:10
Industry Overview - Health and fitness companies focus on improving physical well-being through products and services such as gym memberships, fitness equipment, nutritional supplements, and wellness programs [1] - The industry benefits from consistent demand driven by growing global awareness of health issues and the importance of physical fitness, supported by rising rates of lifestyle-related diseases and a growing emphasis on preventive healthcare [3] - Diverse revenue streams, including subscriptions, product sales, and services, make the health and fitness sector attractive to investors seeking long-term gains [4] Investment Opportunities - Five recommended stocks in the health and fitness space with favorable Zacks Rank include Sprouts Farmers Market Inc. (SFM), DexCom Inc. (DXCM), Hims & Hers Health Inc. (HIMS), United Natural Foods Inc. (UNFI), and GoodRx Holdings Inc. (GDRX) [2] Company Highlights Sprouts Farmers Market Inc. (SFM) - Focus on product innovation, e-commerce, private label offerings, and targeted marketing has led to better-than-expected fourth-quarter 2024 results, with both top and bottom lines growing year over year [6] - Expected net sales growth of 10.5% to 12.5% and comparable store sales increase of 4.5% to 6.5% for 2025 [7] - Projected revenue and earnings growth rates of 13.7% and 33.6%, respectively, for the current year [8] DexCom Inc. (DXCM) - Benefiting from strong contributions from the Sensor segment and both domestic and international revenue growth [10] - Expected revenue and earnings growth rates of 14.3% and 23.2%, respectively, for the current year [11] Hims & Hers Health Inc. (HIMS) - Addresses a $360 million U.S. total addressable market across various healthcare specialties, with over 2 million subscribers driving recurring revenues [12] - Expected revenue and earnings growth rates of 58.5% and more than 100%, respectively, for the current year [13] United Natural Foods Inc. (UNFI) - Demonstrating strong growth supported by wholesale momentum and demand for natural and organic products [14] - Expected revenue and earnings growth rates of 1.9% and more than 100%, respectively, for the current year [16] GoodRx Holdings Inc. (GDRX) - Offers a price comparison platform for prescription drugs, enabling consumers to save on purchases [17] - Expected revenue and earnings growth rates of 4% and 14.7%, respectively, for the current year [19]